The 2026 Integrative Medicine Depression Treatment Guide

The integrative medicine approach to depression treatment

Integrative medicine treats depression as what the science now shows it to be — a final common pathway with many possible drivers, not a single “chemical imbalance” fixed by one drug. Rather than trying antidepressant after antidepressant, it looks at inflammation, the gut-brain axis, sleep, hormones, neuroplasticity, trauma and the effect of chronic illness together, and stacks treatments so the whole plan works better than the sum of its parts. This is the Integrative Medicine Depression Treatment Guide: what we commonly find when we assess someone properly, and what we most often see help — including the natural, functional and newer medical options standard depression care rarely brings together.

What depression is, and why standard drugs often fall short

Depression is a complex illness, and no two people’s depression is exactly the same — which is a large part of why standard drug approaches are ineffective in an estimated 29–46% of cases. Two people with the same diagnosis can respond completely differently because their triggers, genes, epigenetic changes and life experiences differ. Depression is best understood as a final common pathway rather than a single disease, and it is no longer thought to be simply a “serotonin deficiency”.

This matters because it explains why so many people cycle through medication after medication without full relief — particularly where biomarkers of inflammation are elevated, which predicts a poorer response to SSRIs. When the underlying contributors are never examined, it can become a frustrating cycle of worsening mood, a life that feels smaller, and less hope of getting better over time. An evidence-based holistic approach is designed to connect the dots, find the real drivers, and remove the overwhelm of trying to navigate it alone.

Depression, chronic illness and the kindling effect

Depression often arrives alongside other conditions — chronic pain, connective tissue disorders such as EDS, chronic fatigue/ME and long covid — which can cause or worsen it. It frequently sets in after years of coping with a chronic illness, even in someone who was never depressed before, because the disruption to life, and the brain’s protective “retreat and avoid” response to ongoing pain or fatigue, lay depression on top. These overlapping symptoms are hard to tease apart, and standard specialists rarely look beyond their own area, which leads to multiple ineffective or high-side-effect drugs and fragmented care.

In recurrent or chronic depression, the brain also becomes more vulnerable to stress triggers through a process called kindling — involving central nervous system dysfunction and reduced neuroplasticity, the brain’s ability to build new connections and adapt. Kindling also worsens sleep, reducing restorative slow-wave sleep and further dysregulating the brain. This is precisely why treatments that work on neuroplasticity — such as medical cannabis and ketamine therapy — can help where traditional drugs have not, and why restoring sleep is such an important lever.

What causes depression: the integrative medicine view

Depression is an acquired condition with genetic influences, and its causes are multifactorial — the exact mix differs from person to person. The contributors we assess include:

• Cognitive brain neural networking and neurotransmitter levels
• Genetics and epigenetic change
• Inflammatory chemicals — some subtypes of depression carry higher inflammatory markers
• Hormone changes and sleep-wake cycle regulation
• The microbiome and the gut-brain axis
• Toxic chronic stress and trauma history
• Lifestyle factors — sleep, exercise and diet
• Environmental influences, including toxin and pollution exposure
• Pain conditions and other chronic illness
• Neurodivergence — adults and young people with autism often become depressed, especially where autism goes unrecognised and overlaps with “ASD burnout”

Understanding which of these are driving a particular person’s depression is what allows treatment to be genuinely personalised, rather than one drug applied to everyone.

The conditions that travel with depression

Depression rarely travels alone, and the conditions it accompanies both cause it and are worsened by it. Treating them together — especially the brain-fog and fatigue components that conventional antidepressants rarely touch — is essential:

Chronic pain, EDS, fatigue & long covid

Chronic pain, connective tissue disorders such as EDS, chronic fatigue/ME and long covid can all drive depression through inflammation, disrupted sleep and the toll of ongoing illness. Depression in the context of chronic illness is under-recognised and under-treated, and treating the two together is often what finally shifts things.

Anxiety, sleep & trauma

Anxiety very commonly coexists with depression, as do disrupted sleep and a history of trauma — and where trauma is a driver, the right kind of therapy matters, since standard CBT is not generally effective for trauma.

Neurodivergence & burnout

Autistic and ADHD adults and young people are more prone to depression, particularly where their neurodivergence has gone unrecognised and tipped into burnout. We assess for this and, where relevant, manage it together, linking to our neurodivergence pathway.

Depression and functional medicine testing

What we find

There is no standard blood test that diagnoses depression — it is a clinical diagnosis — but some subtypes carry higher inflammatory biomarkers, and functional testing can reveal contributors that standard care misses: stress-tolerance and resilience markers, gut-microbiome patterns linked to mood, inflammatory biomarkers, circadian rhythm dysfunction and mitochondrial function.

What we commonly see work

Where used, testing helps further personalise treatment to the underlying drivers of a particular person’s depression — targeting inflammation, the gut, the body clock or cellular energy rather than guessing. It is one input alongside a careful clinical assessment, and it can help track progress over time so you and your medical team can see what is actually working.

Depression diet and the gut microbiome

What we find

Diet influences depression largely through its effect on the microbiome and on the neurotransmitters made in the gut. Processed, pro-inflammatory diets are associated with worse depression, and an anti-inflammatory approach is increasingly recognised as having a genuine role in treatment.

What we commonly see work

There is no single depression diet. A whole-foods Mediterranean pattern is tied to a lower risk of developing depression, though on its own it is unlikely to put an established depression into remission. For some people, particularly with certain biomarkers, a modified ketogenic diet can improve symptoms, though it needs tailoring to be sustainable. The best approach is guided by your symptom cluster, depression subtype, and gut and blood biomarkers — alongside repairing the gut and rebalancing the microbiome, which affects mood through the gut-brain axis.

Medical cannabis for depression

Medical cannabis is a legal medicine in the UK, available on private prescription from a specialist doctor. It is a whole-plant medicine, and different strains and chemovars produce different effects on mood, making it a highly personalised medicine. It works on endocannabinoid system dysregulation, the HPA-axis stress response, the serotonin system and inflammation pathways — and, importantly, it encourages neuroplasticity, which is akin to the opposite of the kindling process in chronic depression.

What we find

Medical cannabis can help people with treatment-resistant depression and related mood disorders where standard medication and therapy have not lifted chronically low mood, and it can also help the mental function, motivation, sleep disturbance, anxiety and pain that so often accompany depression and are hard to treat with standard drugs. Many people notice meaningful improvement within the first month.

What we commonly see work

Specific strains are chosen for day versus night — to lift mood during the day and restore deeper sleep at night. This is very different from recreational cannabis: high-dose THC can worsen anxiety or trigger panic, because THC does opposite things at different doses and with or without CBD. Over-the-counter hemp CBD is not the same as medical cannabis, and many hemp products are rich in the sedating terpene myrcene, which may not suit someone already feeling low or sluggish. Dr Dani Gordon, our medical director, is the UK’s most experienced cannabinoid medicine physician and trained the first UK psychiatrists to prescribe medical cannabis for mood disorders.

Educational information about a specialist-prescribed treatment; not medical advice or a recommendation to use any specific medicine.

Nervous system and mindbody medicine for depression

What we find

Because so many people with depression also carry anxiety and a dysregulated stress response, calming the nervous system is an important lever — and specific mindbody practices have a direct effect on the brain, not just an indirect one.

What we commonly see work

Relaxation-response techniques lower stress and anxiety, while mindfulness-based programmes and compassion or loving-kindness meditation have been shown to have a direct antidepressant effect on the brain, and can be combined with other treatments. CBT can be very helpful for certain “cognitive-affective” subtypes of depression, though not for everyone, and where trauma is involved, other forms of psychotherapy are more appropriate, since CBT is not generally effective for trauma. Home neuromodulation and biofeedback devices — which have positive evidence in depression even as a sole treatment — and bright light therapy combined with brief morning activity are used where they fit, always tailored to the person and combined with the rest of the plan.

Movement and exercise for depression

What we find

Specific forms of exercise can help depression by stimulating endorphin release and supporting mood, and physical activity is one of the more reliable non-drug levers. But when someone is deeply depressed, fatigued or also in chronic pain, “just get more active” is far easier said than done, and generic advice can add to the sense of failure.

What we commonly see work

We build movement in gently and realistically, matched to the person’s energy and any overlapping pain or fatigue — often starting small, paired with morning light, and increasing as mood and motivation improve. As with everything in the plan, the aim is something sustainable rather than a burst that cannot be maintained.

Supplements and nutraceuticals for depression

What we find

Nutrients, botanicals, medicinal fungi and adaptogens can help different aspects of depression, but most drugstore supplements use ineffective doses or single ingredients that lack a synergistic effect and are usually disappointing for clinical depression. Supplements alone rarely produce remission — they work as part of a holistic plan, with the dose and combination personalised.

What we commonly see work

Each person’s stack is different, but it may include:

• SAM-e (avoided in bipolar depression), folate and methylfolate
• Vitamin D where low
• High-EPA omega-3s
• Saffron standardised extract and, where appropriate, St John’s Wort
• Specific probiotics for the gut-brain axis
• Cordyceps and lion’s mane mushrooms
• Trace minerals, including ultra-low-dose lithium orotate
• Mitochondrial support such as NAD+ precursors in “sluggish” depression

Everything is matched to your case and reviewed over time. Some of these interact with prescribed medicines, so they are always used under medical guidance.

Medication and novel medicines for depression

What we find

Standard antidepressants — SSRIs, SNRIs and tricyclics — help many people, but possibly nearly half do not respond fully or at all, and others have to stop because of intolerable side effects. Being told your depression is “treatment-resistant” often means the biology driving it has not yet been addressed, rather than that nothing can help.

What we commonly see work

Holistic does not mean anti-medicine. Where medication helps, we manage it carefully to reduce side effects, and where it has failed, we consider newer options that work on neuroplasticity. Medical cannabis is one; ketamine therapy, now legally available privately in the UK for treatment-resistant depression, can be very effective and is often combined with medical cannabis and the wider holistic plan for long-standing, severe cases. Psilocybin remains in the research phase in the UK and is not offered as a clinical treatment here, but is a promising area for the future. All of this is coordinated within one personalised plan.

Your environment and depression

What we find

Our environment interacts with our genes to shape mood. Air quality and air pollution are now recognised risk factors for developing depression, and poor sleep environments and low daylight can all keep mood low.

What we commonly see work

• Improving indoor air quality with a good air purifier in the bedroom and main living space, filtering mould spores and chemical off-gassing
• Air-cleaning houseplants such as snake plants, spider plants and ferns, which also have mood benefits
• Protecting sleep and supporting the body clock with morning light and reduced evening screens
• Infrared saunas and cold-water immersion for some people, introduced gradually and only after discussing with a doctor
• Home neuromodulation and biofeedback devices where prescribed

Small changes to the home environment can meaningfully support the rest of the plan.

Depression across the lifespan

Depression presents differently at different ages, and we see teenagers and adults. In teenagers, low mood often emerges alongside anxiety, sleep disruption and the pressures of school, and in high-masking young people it can be the visible sign of unrecognised autism or ADHD tipping into burnout — which is why looking for neurodivergent and biological drivers, rather than only prescribing, matters so much at this age. In adults, depression is frequently recurrent or chronic, shaped by the kindling effect, by overlapping chronic illness and pain, and by years of stress and disrupted sleep; here the work is to find and treat the specific drivers and restore neuroplasticity and sleep. Our adult service sees patients aged 18 and over; younger patients are supported through our dedicated children’s and teens’ pathways, so families can be seen across the age range.

What an integrative plan can look like

Frequently asked questions

Depression often improves substantially with an integrative, whole-system approach that treats its real drivers — functional testing, anti-inflammatory and gut-focused nutrition, targeted supplements, nervous system and mindbody work, and medical cannabis or newer options such as ketamine where appropriate — used alongside carefully managed medication rather than instead of it.

For some people, yes — particularly in treatment-resistant depression, and for the low motivation, poor sleep, anxiety and pain that accompany it. It is a legal, specialist-prescribed medicine that works on the endocannabinoid system and encourages neuroplasticity, with day and night formulations. It is one option within a wider plan, and is quite different from recreational cannabis.

Being told your depression is “treatment-resistant” usually means the underlying biology hasn’t yet been addressed, not that nothing can help. We look for the specific contributors — inflammation, gut, sleep, hormones, trauma, neurodivergence — and can consider neuroplasticity-based options such as medical cannabis and, for treatment-resistant depression, ketamine therapy.

Yes. Our adult service sees patients aged 18 and over, and we have dedicated children’s and teens’ pathways — important because in young people, depression is often linked to unrecognised neurodivergence and burnout. Please contact the clinic and we will direct you to the right pathway.

Very often. Depression frequently follows chronic pain, EDS, chronic fatigue or long covid, and is more common in autistic and ADHD people, especially where neurodivergence is unrecognised. We treat these together rather than in isolation, and link to our neurodivergence pathway.

Integrative medicine, delivered by specialist doctors

• We treat depression as a final common pathway. We look for the real drivers — inflammation, gut, sleep, hormones, trauma, chronic illness, neurodivergence — not just prescribe another antidepressant.
• Specialist medical doctors only. Every consultation is with a doctor who can prescribe and investigate, not a fixed protocol.
• A bigger toolbox, including neuroplasticity-based options. Functional medicine, nutrition, nervous system work, medical cannabis and ketamine therapy for treatment-resistant depression, stacked for effect.
• Personalised and hopeful. People can and do get well again, even after many treatments have failed — with the right combination, at the right time.